GlassScriptPhysician profile
Ahsanul Haque
NPI 1558364372
$23,893.93
in general payments reported to CMS, 2019-2025
78 companies · $6,913 in 2025
The $6,913 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,515 · 2020: $1,075 · 2021: $1,805 · 2022: $1,015 · 2023: $4,796 · 2024: $4,775 · 2025: $6,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $2,238 · Education: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,993.34 |
| Consulting Fee | $2,237.50 |
| Education | $1,252.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,548.96 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Eisai INC. | $2,093.71 | 2019-2025 | |
| Janssen Biotech, INC. | $1,415.31 | 2019-2025 | Rybrevant, Tecvayli, Erleada |
| Astrazeneca Pharmaceuticals LP | $1,189.75 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Novartis Pharmaceuticals Corporation | $1,169.47 | 2019-2025 | |
| Pfizer INC. | $1,082.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,016.22 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $865.44 | 2019-2025 | Vyloy, Padcev, Xospata |
| Genzyme Corporation | $790.10 | 2019-2025 | |
| Glaxosmithkline, LLC. | $786.27 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Ipsen Biopharmaceuticals, INC | $667.50 | 2022-2025 | Onivyde, Tazverik |
| Amgen INC. | $629.82 | 2019-2023 | Nplate, Xgeva, Vectibix |
| Genentech USA, INC. | $553.80 | 2019-2025 | Venclexta, Phesgo, Perjeta |
| Cardinal Health 110 LLC | $550.00 | 2025 | |
| Exelixis INC. | $525.21 | 2019-2025 | Cabometyx |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $506.26 | 2019-2025 | Enhertu, Injectafer, Vanflyta |
| Celgene Corporation | $495.04 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Lilly USA, LLC | $491.10 | 2019-2025 | Jaypirca, Retevmo, Verzenio |
| Stemline Therapeutics INC. | $476.59 | 2023-2025 | Orserdu |
| Gilead Sciences, INC. | $425.36 | 2019-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $401.81 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $356.48 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $352.45 | 2019-2025 | |
| Incyte Corporation | $348.28 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Abbvie INC. | $300.71 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $269.17 | 2019-2024 | Xarelto |
| Seagen INC. | $241.05 | 2022-2023 | Tukysa, Padcev |
| Regeneron Healthcare Solutions, INC. | $196.43 | 2021-2025 | Libtayo |
| Array Biopharma INC | $175.90 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Takeda Pharmaceuticals U.S.A., INC. | $170.66 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Amneal Pharmaceuticals LLC | $165.75 | 2023-2025 | Avastin, Alymsys |
| Adaptive Biotechnologies Corporation | $159.77 | 2023-2025 | Clonoseq |
| Tesaro, INC. | $151.95 | 2019 | |
| Janssen Scientific Affairs, LLC | $150.00 | 2025 | Talvey |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.76 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $144.50 | 2019-2024 | Ultomiris |
| Pharmaessentia USA Corporation | $143.96 | 2024-2025 | Besremi |
| Puma Biotechnology, INC. | $136.48 | 2019-2025 | |
| Tempus Ai, INC | $110.81 | 2024-2025 | Xt Cdx |
| Comsort, INC | $100.00 | 2019 | |
| Clovis Oncology, INC. | $95.00 | 2019 | |
| Sobi, INC | $86.68 | 2023-2025 | |
| Coherus Oncology, INC. | $84.28 | 2023-2024 | |
| Mirati Therapeutics, INC. | $82.56 | 2023-2024 | Krazati |
| Kite Pharma, INC. | $81.03 | 2020-2023 | Yescarta |
| Emd Serono, INC. | $77.36 | 2019-2023 | Bavencio, Mavenclad |
| Deciphera Pharmaceuticals INC. | $72.52 | 2022-2023 | Qinlock |
| Geron Corporation | $51.72 | 2025 | Rytelo |
| Blueprint Medicines Corporation | $50.75 | 2021-2023 | Ayvakit |
| Adc Therapeutics America, INC. | $50.24 | 2023 | |
| Argenx US, INC. | $46.82 | 2024-2025 | Vyvgart |
| Aveo Pharmaceuticals, INC. | $39.07 | 2025 | |
| Sumitomo Pharma America, INC. | $38.87 | 2024-2025 | Orgovyx |
| Beigene USA, INC. | $38.02 | 2024 | Brukinsa, Tevimbra |
| Spectrum Pharmaceuticals INC. | $35.28 | 2023-2025 | Rolvedon |
| Servier Pharmaceuticals LLC | $34.27 | 2022-2024 | |
| Rigel Pharmaceuticals, INC. | $33.72 | 2021-2025 | Tavalisse |
| Pharmacosmos Therapeutics INC. | $29.72 | 2020-2025 | Monoferric |
| Sanofi US Services INC. | $29.01 | 2023 | |
| Beone Medicines USA, INC. | $27.34 | 2025 | Tevimbra |
| Morphosys, US INC. | $26.51 | 2021 | |
| Dova Pharmaceuticals | $25.98 | 2020 | |
| Acceleron Pharma, INC. | $21.71 | 2020 | |
| Curium US LLC | $21.69 | 2025 | Detectnet |
| Progenics Pharmaceuticals, INC. | $21.13 | 2023 | Pylarify |
| G1 Therapeutics, INC. | $20.11 | 2023 | Cosela |
| Tersera Therapeutics LLC | $19.58 | 2023 | Zoladex |
| Recordati_rare_diseases_inc. | $17.59 | 2025 | Enjaymo |
| Immunocore Limited | $17.09 | 2025 | Kimmtrak |
| Cti Biopharma Corp. | $16.17 | 2022 | |
| Legend Biotech USA INC. | $15.91 | 2025 | Carvykti |
| Global Blood Therapeutics, INC. | $14.25 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $13.17 | 2019 | |
| Sandoz INC. | $13.07 | 2019 | |
| Innate Pharma, INC | $12.96 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.86 | 2019 | |
| Shionogi INC | $11.36 | 2019 | |
| Secura Bio, INC. | $7.99 | 2019 |
Drugs and devices associated with these payments
Lenvima $1,977Opdivo $700Keytruda $537Enhertu $495Jemperli $484Zejula $484Orserdu $477Rybrevant $435Onivyde $384Cabometyx $329Ibrance $317Tukysa $308Kisqali $283Lynparza $276Tazverik $269Scemblix $242Pluvicto $237Zepzelca $236Eliquis $229Reblozyl $218Stivarga $217Vitrakvi $217Jaypirca $207Trodelvy $202Comirnaty $189Talvey $183Tecvayli $182Padcev $180Paxlovid $173Sarclisa $172Venclexta $172Opdualag $171Krazati $164Imfinzi $162Clonoseq $160Erleada $154Darzalex $150Imbruvica $148Jakafi $148Besremi $144Jevtana $141Braftovi $141Mektovi $141Bosulif $136Nplate $135Xgeva $135Phesgo $130Libtayo $125Vectibix $123Ultomiris $121Retevmo $115Verzenio $115Ojjaara $113Avastin $108Perjeta $107Lorbrena $105Tecentriq $101Pomalyst $99.03Keytruda Qlex $95.25Xt Cdx $95.16Nubeqa $92.65Udenyca $84.28Tasigna $77.48Orgovyx $70.75Carvykti $70.17Kadcyla $67.32Xtandi $62.41Vyloy $61.84Kyprolis $61.51Polivy $59.73Alymsys $57.75Enjaymo $54.47Qinlock $52.90Rytelo $51.72Piqray $50.39Adcetris $49.99Lumakras $48.54Lutathera $47.57Xalkori $47.51Vyvgart $46.82Fruzaqla $45.42Injectafer $44.68Vanflyta $44.20Alecensa $42.98Tevimbra $41.34Alunbrig $40.59Fotivda $39.07Cablivi $36.88Blincyto $36.38Xarelto $35.55Rolvedon $35.28Onglyza $34.70Yescarta $33.88Calquence $33.85Ubrelvy $33.72Vonjo $33.68Ayvakit $33.06Elrexfio $32.70Doptelet $32.58Talzenna $30.53
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahsanul Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.